Loading financials from SEC filings…
Semiconductors · Technology · Fiscal year ends Oct 3
Kulicke & Soffa Industries reported revenue of $654M in the fiscal year ended Oct 2025, down 7.4% from the year before. Operating income was −$3M, an operating margin of −0.5%, and net income was $213,000. Operating cash flow of $114M less capital expenditure of $17M left free cash flow of $96M.
Ranks among the 51 semiconductors companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.
Last 5 fiscal years
| Fiscal year | Oct 2021 | Oct 2022 | Sep 2023 | Sep 2024 | Oct 2025 |
|---|---|---|---|---|---|
| Revenue | 1,518 | 1,504 | 742 | 706 | 654 |
| Cost of revenue | 821 | 755 | 384 | 437 | 376 |
| Gross profit | 697 | 748 | 359 | 269 | 278 |
| Research & development | 137 | 137 | 145 | 151 | 150 |
| Selling, general & admin | 147 | 140 | 153 | 166 | 168 |
| Operating income | 412 | 470 | 39.4 | −92.5 | −3.2 |
| Interest expense | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 |
| Pre-tax income | 415 | 477 | 72.2 | −58.4 | 20.5 |
| Income tax | 47.3 | 43.4 | 15.1 | 10.7 | 20.3 |
| Net income | 367 | 434 | 57.1 | −69.0 | 0.2 |
| Diluted EPS | 5.78 | 7.09 | 0.99 | −1.24 | 0.00 |
| Diluted shares | 63.5 | 61.2 | 57.5 | 55.6 | 53.2 |
| Fiscal year | Oct 2021 | Oct 2022 | Sep 2023 | Sep 2024 | Oct 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | 363 | 556 | 529 | 227 | 216 |
| Receivables | 421 | 309 | 159 | 194 | 184 |
| Inventory | 167 | 185 | 217 | 178 | 160 |
| Current assets | 1,352 | 1,332 | 1,189 | 995 | 902 |
| Net PP&E | 68.0 | 80.9 | 110 | 64.8 | 59.0 |
| Goodwill | 72.9 | 68.1 | 88.7 | 89.7 | 69.5 |
| Total assets | 1,602 | 1,589 | 1,500 | 1,240 | 1,104 |
| Payables | 155 | 67.3 | 49.3 | 58.8 | 57.2 |
| Deferred revenue | 15.6 | 3.2 | 4.8 | 18.6 | 23.9 |
| Current liabilities | 352 | 249 | 182 | 184 | 188 |
| Total liabilities | 506 | 394 | 325 | 296 | 283 |
| Shareholders' equity | 1,095 | 1,195 | 1,175 | 944 | 821 |
| Fiscal year | Oct 2021 | Oct 2022 | Sep 2023 | Sep 2024 | Oct 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 300 | 390 | 173 | 31.0 | 114 |
| Capital expenditure | 22.8 | 23.0 | 44.4 | 16.1 | 17.2 |
| Free cash flow | 277 | 367 | 129 | 14.9 | 96.4 |
| Depreciation & amortisation | 19.8 | 21.3 | 28.9 | 24.7 | 18.0 |
| Stock-based compensation | 15.5 | 19.0 | 22.7 | 26.9 | 28.5 |
| Acquisitions | 26.3 | 0.0 | 36.9 | 0.0 | – |
| Share buybacks | 10.4 | 281 | 69.2 | 151 | 97.1 |
| Dividends paid | 33.5 | 39.4 | 42.0 | 44.2 | – |
| Dividend per share | 0.56 | 0.17 | 0.19 | 0.80 | 0.82 |
| Fiscal year | Oct 2021 | Oct 2022 | Sep 2023 | Sep 2024 | Oct 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | −0.9% | −50.6% | −4.9% | −7.4% |
| Operating income growth (YoY) | – | 14.0% | −91.6% | −334.5% | – |
| EPS growth (YoY) | – | 22.7% | −86.0% | −225.3% | – |
| Gross margin | 45.9% | 49.8% | 48.3% | 38.1% | 42.5% |
| Operating margin | 27.2% | 31.3% | 5.3% | −13.1% | −0.5% |
| Net margin | 24.2% | 28.8% | 7.7% | −9.8% | 0.0% |
| Return on equityBlank when equity is negative | 33.5% | 36.3% | 4.9% | −7.3% | 0.0% |
| ROCEEBIT ÷ (assets − current liabilities) | 33.0% | 35.1% | 3.0% | −8.8% | −0.4% |
| Free cash flow margin | 18.3% | 24.4% | 17.4% | 2.1% | 14.7% |
| Cash conversion (CFO ÷ net income) | 0.82x | 0.90x | 3.03x | −0.45x | 533x |
| Receivable days | 101 | 75 | 78 | 100 | 102 |
| Inventory days | 74 | 89 | 207 | 148 | 155 |
| Payable days | 69 | 33 | 47 | 49 | 55 |
| Interest cover | 1892x | 2260x | 278x | −1039x | −24.1x |
| Current ratio | 3.84x | 5.36x | 6.55x | 5.41x | 4.79x |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.